JULIE MILTON: Open Payments
NPI 1912523788 · SAINT LOUIS, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,867 in 24 payments from 12 companies in 2025. Trend: 2023 $1,187 · 2024 $1,735 · 2025 $1,867
Food & beverage: $1,867
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 5 | $426 |
| Axsome Therapeutics, Inc. | 2 | $250 |
| Novo Nordisk Inc | 7 | $237 |
| Collegium Pharmaceutical, Inc. | 2 | $178 |
| Abbott Laboratories | 1 | $162 |
| Amgen Inc. | 1 | $129 |
| Tris Pharma Inc | 1 | $110 |
| ABBVIE INC. | 1 | $101 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $101 |
| Corcept Therapeutics | 1 | $89 |
Products named: Auvelity, AIRSUPRA, Jornay PM, FREESTYLE LIBRE 3, Ozempic, FASENRA, Dyanavel XR, VRAYLAR.
Industry payments across MO — which companies pay providers there.
